GB1109539A - New pyridoxine derivative, process for its preparation and therapeutic composition containing same - Google Patents
New pyridoxine derivative, process for its preparation and therapeutic composition containing sameInfo
- Publication number
- GB1109539A GB1109539A GB5813166A GB5813166A GB1109539A GB 1109539 A GB1109539 A GB 1109539A GB 5813166 A GB5813166 A GB 5813166A GB 5813166 A GB5813166 A GB 5813166A GB 1109539 A GB1109539 A GB 1109539A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pyridoxine
- glyoxylic acid
- preparation
- composition containing
- therapeutic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 abstract 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 6
- 235000008160 pyridoxine Nutrition 0.000 abstract 3
- 239000011677 pyridoxine Substances 0.000 abstract 3
- 229940011671 vitamin b6 Drugs 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000000269 nucleophilic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
- C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR44607A FR4970M (enExample) | 1966-01-03 | 1966-01-03 | |
| FR87172 | 1966-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1109539A true GB1109539A (en) | 1968-04-10 |
Family
ID=26167914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5813166A Expired GB1109539A (en) | 1966-01-03 | 1966-12-29 | New pyridoxine derivative, process for its preparation and therapeutic composition containing same |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE691821A (enExample) |
| DE (1) | DE1695354B1 (enExample) |
| ES (1) | ES335167A1 (enExample) |
| GB (1) | GB1109539A (enExample) |
-
1966
- 1966-12-27 BE BE691821D patent/BE691821A/xx not_active IP Right Cessation
- 1966-12-29 GB GB5813166A patent/GB1109539A/en not_active Expired
-
1967
- 1967-01-02 ES ES0335167A patent/ES335167A1/es not_active Expired
- 1967-01-02 DE DE19671695354 patent/DE1695354B1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BE691821A (enExample) | 1967-05-29 |
| ES335167A1 (es) | 1967-12-01 |
| DE1695354B1 (de) | 1971-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES465906A1 (es) | Un procedimiento de preparacion de comprimidos | |
| BE616919A (fr) | Procédé de préparation de dérivés d'acides | |
| ES427079A1 (es) | Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7. | |
| ES8400742A1 (es) | Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co. | |
| DE2963010D1 (en) | 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture | |
| BE816573Q (en) | Medicament containing a pyridoxine derivative | |
| GB977237A (en) | 4-substituted amino-7-chloroquinolines | |
| DE2963545D1 (en) | Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation | |
| FR2236488B1 (enExample) | ||
| ES435604A1 (es) | Procedimiento para la preparacion de derivados de indolila- cetilaminoacidos. | |
| JPS55122715A (en) | Antidiabetic agent | |
| ES341731A1 (es) | Procedimiento para la fabricacion de acilderivados de la proscilaridina a. | |
| SE7607630L (sv) | Forening for behandling av bovin mastit | |
| ES342394A1 (es) | Procedimiento para la produccion de nuevas 2-bencilamino-i-mida-zolinas-(2). | |
| CH532596A (fr) | Procédé de préparation de dérivés pharmaceutiquement actifs de l'indole | |
| GB976096A (en) | Pharmaceutical compositions | |
| JPS5721319A (en) | Agent for improving desorder of circulatory orgen | |
| GB1060069A (en) | Improvements in or relating to phenylethanolamines | |
| ES335172A1 (es) | Procedimiento para la preparacion de un medicamento de accion coleretica. | |
| GB1006728A (en) | Amine salts of pyrrolidone carboxylic acid | |
| GB1141702A (en) | Therapeutic compositions | |
| GB1029050A (en) | Improvements in and relating to new flavone and the process of preparation and application thereof | |
| GB956231A (en) | Improvements in or relating to derivatives of nitrofuran | |
| JPS5569510A (en) | Carcinostatic agent | |
| US2720525A (en) | Quinoline salts of amic acids |